PYC Therapeutics (ASX: PYC)

PYC Therapeutics is an Australian biotechnology company listed on the ASX (Australian Securities Exchange) under the ticker PYC. From my training data, I know it is a clinical-stage biopharmaceutical company focused on developing treatments for genetic diseases, particularly in ophthalmology and neurology. The company appears to have some visibility in financial and biotech circles, but likely has limited mainstream recognition outside specialized investment and medical communities. Its AI visibility is constrained by being a relatively niche player in the biotech sector with targeted therapeutic focus areas.